Targeted therapy achieves responses across multiple cancer types with FGFR alterations
Three clinical trials led by researchers at The University of Texas MD Anderson Cancer Center demonstrated positive results from the targeted therapy erdafitinib for patients with multiple tumor types harboring FGFR alterations. ...
Jun 5, 2023
0
2